Internal Medicine
Editorial – SARS-CoV2 Vaccines: Slow is Fast
25 May, 2020 | 01:54h | UTCSARS-CoV2 vaccines: Slow is fast – Science
Promising Early Results with New Vaccine from China in Phase I Trial
25 May, 2020 | 01:57h | UTCCommentaries: First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response – The Lancet AND Early Study Of Covid-19 Vaccine Developed In China Sees Mixed Results – Forbes AND Coronavirus Vaccine Shows Promising Early Results in China – The New York Times AND A Chinese biotech just published the first human data for its coronavirus vaccine candidate, supporting further trials – Business Insider AND Experts skeptical after researchers report positive vaccine results – CNN AND Two COVID-19 Vaccine Candidates Induce Immune Response In Healthy Volunteers – Health Policy Watch
Study: 10 of 60 Patients Treated for COVID-19 Persisted with Positive RT-PCR Results from 4 to 24 Days After Hospital Discharge
25 May, 2020 | 01:50h | UTCCommentaries: Expert reaction to study on PCR testing results from 60 people after clinical recovery from COVID-19 – Science Media Centre AND 16% of recovered patients test positive for COVID-19 weeks after discharge: study – UPI
Meta-Analysis: Corticosteroids May Reduce Mortality for Patients with COVID-19 and ARDS
25 May, 2020 | 01:45h | UTC
Clinical Guidance: Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic
25 May, 2020 | 01:43h | UTCRelated: Coagulation abnormalities and thrombosis in patients with COVID-19 – The Lancet AND COVID-19 and its implications for thrombosis and anticoagulation – Blood AND Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines – Thrombosis and Haemostasis AND Thrombosis and COVID-19: FAQs For Current Practice – American College of Cardiology
Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach
25 May, 2020 | 01:42h | UTC
[Abstract Only] Randomized Trial: Haloperidol Effective for the Treatment of Headache in the Emergency Department
25 May, 2020 | 01:33h | UTC
Cohort Study: Prognostic Factors Associated with Adverse Outcomes Among Patients with Covid-19
25 May, 2020 | 01:35h | UTCEditorial: Covid-19 care before, during, and beyond the hospital
Commentary: Age, male sex, obesity, and underlying illness risk factors for severe COVID-19 or death – The BMJ
Cohort Study: Fluconazole Use in the First Trimester of Pregnancy Linked to Increased Risk of Musculoskeletal Malformations
25 May, 2020 | 01:31h | UTCCommentary: Musculoskeletal Malformations Up With Fluconazole in Pregnancy – Physician’s Weekly
Choosing Wisely in the COVID-19 Era: Preventing Harm to Healthcare Workers
22 May, 2020 | 04:58h | UTC
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
22 May, 2020 | 04:59h | UTCCommentary: Lungs of deceased COVID-19 patients show distinctive features – Brigham and Women’s Hospital
Related: Postmortem Examination of Patients With COVID-19 – JAMA AND Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series – Annals of Internal Medicine AND Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 – Journal of Thrombosis and Haemostasis
How Coronavirus Lockdowns Stopped Flu in its Tracks
22 May, 2020 | 04:53h | UTCHow coronavirus lockdowns stopped flu in its tracks – Nature
“Reported rates of influenza and other infections have fallen sharply, but some communicable diseases may see a rise.”
15 Drugs Being Tested to Treat COVID-19 and How They Would Work
22 May, 2020 | 04:52h | UTC15 drugs being tested to treat COVID-19 and how they would work – Nature
[Preprint] IL6 Inhibition in Critically Ill COVID-19 Patients is Associated with Increased Secondary Infections
22 May, 2020 | 04:44h | UTC
Opinion: Revisiting the No Visitors Policy
22 May, 2020 | 04:43h | UTCRevisiting the No Visitors Policy – CMAJ Blogs
“I follow the policy, as I must, but neither my heart nor my mind believe that the harm we aim to prevent with current no visitors edicts outweighs the harm we are causing.”
Wide Complex Tachycardia Differentiation: A Reappraisal of the State‐of‐the‐Art
22 May, 2020 | 04:38h | UTC
Observational Study Suggests Possible Benefit from Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
21 May, 2020 | 09:23h | UTCRelated: Study Commentary: Before/after Study of Short-Course Steroid in COVID-19
Olfactory Dysfunction in COVID-19: Diagnosis and Management
21 May, 2020 | 09:24h | UTCOlfactory Dysfunction in COVID-19: Diagnosis and Management – JAMA
Related: Loss of smell and taste as symptoms of COVID-19: what does the evidence say? – CEBM Oxford
Characteristics and Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease
21 May, 2020 | 09:18h | UTCCommentary: Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease – American College of Cardiology
Cardiovascular Considerations in Treating Patients with COVID-19
21 May, 2020 | 09:16h | UTCRelated: Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis – Current Problems in Cardiology AND Cardiology After COVID-19: Physicians Predict Lasting Change – TCTMD
See also: COVID-19: Updates for Cardiologists
Rate of Diagnostic Errors and Related Harms for Major Vascular Events, Infections, and Cancers
21 May, 2020 | 09:14h | UTCCommentary: Misdiagnoses Common, With Permanent Disability, Death for Many – Medscape (free registration required)
Neurologic Complications of COVID-19
21 May, 2020 | 09:15h | UTCNeurologic complications of COVID-19 – American Journal of Emergency Medicine
Related: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries) AND Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 – Neurology
[No Publication Available] Covid-19 Patients Testing Positive After Recovery Aren’t Infectious
20 May, 2020 | 10:00h | UTCCovid Patients Testing Positive After Recovery Aren’t Infectious, Study Shows – Bloomberg
Why Saliva Tests Could Offer a Better Alternative to Nasal COVID-19 Swabs
20 May, 2020 | 09:58h | UTCOriginal Article: Saliva—Friend and Foe in the COVID-19 Outbreak – Diagnostics
Editorial: Lack of Efficacy of Hydroxychloroquine in Covid-19
20 May, 2020 | 10:01h | UTCLack of efficacy of hydroxychloroquine in covid-19 – The BMJ
Original Research: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ
Related Meta-analysis (preprint) Hydroxychloroquine in COVID-19: A systematic review and meta-analysis – medRxiv